Literature DB >> 30257891

Prognostic Nomogram Based on Histological Characteristics of Fibrotic Tumor Stroma in Patients Who Underwent Curative Resection for Intrahepatic Cholangiocarcinoma.

Chu-Yu Jing1, Yi-Peng Fu2, Jin-Long Huang1, Mei-Xia Zhang1, Yong Yi1, Wei Gan1, Xin Xu1, Hu-Jia Shen1, Jia-Jia Lin1, Su-Su Zheng1, Juan Zhang1, Jian Zhou1, Jia Fan1, Zheng-Gang Ren1, Shuang-Jian Qiu3, Bo-Heng Zhang3,4.   

Abstract

BACKGROUND: Fibrotic tumor stroma (FTS) has been implicated in cancer promotion in several neoplasms. The histological features of FTS are convenient and easily accessible in clinical routine in intrahepatic cholangiocarcinoma (ICC) specimens. The goal of this study was to explore prognostic impacts of the quantity and maturity of FTS on surgical ICC patients. Moreover, we aimed to propose an efficient prognostic nomogram for postoperative ICC patients.
MATERIALS AND METHODS: The clinical profiles of 154 consecutive postoperative ICC patients were retrospectively analyzed. Tumor-stroma ratio and morphological maturity of FTS were evaluated on hematoxylin and eosin-stained tumor sections. CD3, CD8, and α-smooth muscle actin (α-SMA) staining were performed on corresponding tissue microarrays. The nomogram was established on variables selected by multivariate analyses and was validated in 10-fold cross-validation.
RESULTS: Rich tumor stroma and strong α-SMA expression were associated with poor overall survival (OS). However, in multivariate analyses, these two biomarkers failed to stratify both OS and recurrence-free survival (RFS). Immature FTS was correlated with tumor multiplicity, advanced clinical stage, and sparser CD3 and CD8 positive tumor-infiltrating lymphocytes (TILs) and was identified as an independent prognostic indicator for both OS and RFS. The nomogram comprising FTS maturity, tumor number, microvascular invasion, and lymph node metastasis possessed higher predictive power relative to conventional staging systems.
CONCLUSION: Immature FTS was an independent risk factor for survival and was associated with sparser CD3 and CD8 positive TILs in ICC. The prognostic nomogram integrating the maturity of FTS offers a more accurate risk stratification for postoperative ICC patients. IMPLICATIONS FOR PRACTICE: Accumulating evidence has suggested that fibrotic components in tumor microenvironment (TME) play a complicated and vital role in TME reprogramming and cancer progression. However, in clinical practice, the evaluation of fibrotic tumor stroma (FTS) is still neglected to some extent. This study's findings indicated that, in intrahepatic cholangiocarcinoma (ICC), the histological maturity of FTS is a robust prognostic indicator for patients who underwent curative resection. Moreover, prognostic nomogram constructed on the maturity of FTS possessed higher predictive power relative to the conventional tumor-node-metastasis staging systems. Taken together, the evaluation of FTS should be emphasized in clinical routine for more accurate prognostic prediction in postoperative ICC patients. © AlphaMed Press 2018.

Entities:  

Keywords:  Fibrotic tumor stroma; Intrahepatic cholangiocarcinoma; Nomogram; Prognosis

Mesh:

Year:  2018        PMID: 30257891      PMCID: PMC6292551          DOI: 10.1634/theoncologist.2017-0439

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  32 in total

1.  The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma: a special reference of 'scirrhous-type' and 'nonscirrhous-type' growth.

Authors:  K Kajiyama; T Maeda; K Takenaka; K Sugimachi; M Tsuneyoshi
Journal:  Am J Surg Pathol       Date:  1999-08       Impact factor: 6.394

Review 2.  The biology and function of fibroblasts in cancer.

Authors:  Raghu Kalluri
Journal:  Nat Rev Cancer       Date:  2016-08-23       Impact factor: 60.716

3.  X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.

Authors:  Robert L Camp; Marisa Dolled-Filhart; David L Rimm
Journal:  Clin Cancer Res       Date:  2004-11-01       Impact factor: 12.531

4.  Decision curve analysis: a novel method for evaluating prediction models.

Authors:  Andrew J Vickers; Elena B Elkin
Journal:  Med Decis Making       Date:  2006 Nov-Dec       Impact factor: 2.583

5.  The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma.

Authors:  Mert Erkan; Christoph W Michalski; Simon Rieder; Carolin Reiser-Erkan; Ivane Abiatari; Armin Kolb; Nathalia A Giese; Irene Esposito; Helmut Friess; Jörg Kleeff
Journal:  Clin Gastroenterol Hepatol       Date:  2008-07-17       Impact factor: 11.382

6.  Capecitabine Extends Survival for Biliary Tract Cancer.

Authors: 
Journal:  Cancer Discov       Date:  2017-06-01       Impact factor: 39.397

7.  The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma.

Authors:  Lai Mun Wang; Michael A Silva; Zenobia D'Costa; Robin Bockelmann; Zahir Soonawalla; Stanley Liu; Eric O'Neill; Somnath Mukherjee; W Gillies McKenna; Ruth Muschel; Emmanouil Fokas
Journal:  Oncotarget       Date:  2016-01-26

8.  Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers.

Authors:  Andrew J Vickers; Angel M Cronin; Elena B Elkin; Mithat Gonen
Journal:  BMC Med Inform Decis Mak       Date:  2008-11-26       Impact factor: 2.796

9.  Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection.

Authors:  Yi-Peng Fu; Yong Yi; Xiao-Yan Cai; Jian Sun; Xiao-Chun Ni; Hong-Wei He; Jia-Xing Wang; Zhu-Feng Lu; Jin-Long Huang; Ya Cao; Jian Zhou; Jia Fan; Shuang-Jian Qiu
Journal:  Br J Cancer       Date:  2016-03-22       Impact factor: 7.640

Review 10.  Association between tumor-stroma ratio and prognosis in solid tumor patients: a systematic review and meta-analysis.

Authors:  Jiayuan Wu; Caixia Liang; Manyu Chen; Wenmei Su
Journal:  Oncotarget       Date:  2016-10-18
View more
  8 in total

1.  Clinical Characteristics and Prognostic Factors of Patients with Intrahepatic Cholangiocarcinoma with Fever: A Propensity Score Matching Analysis.

Authors:  Zi-Jun Gong; Jian-Wen Cheng; Pin-Ting Gao; Ao Huang; Yun-Fan Sun; Kai-Qian Zhou; Bo Hu; Shuang-Jian Qiu; Jian Zhou; Jia Fan; Xin-Rong Yang
Journal:  Oncologist       Date:  2019-03-25

2.  Prognostic nomogram for predicting cancer-specific survival in patients with resected hilar cholangiocarcinoma: a large cohort study.

Authors:  Zhimin Yu; Qinghua Liu; Hao Liao; Juanyi Shi; Zhenyu Zhou; Yongcong Yan; Junyao Xu; Chuanchao He; Kai Mao; Jianlong Zhang; Jie Wang; Zhiyu Xiao
Journal:  J Gastrointest Oncol       Date:  2022-04

3.  Hepatic stellate cells promote intrahepatic cholangiocarcinoma progression via NR4A2/osteopontin/Wnt signaling axis.

Authors:  Chu-Yu Jing; Yi-Peng Fu; Cheng Zhou; Mei-Xia Zhang; Yong Yi; Jin-Long Huang; Wei Gan; Juan Zhang; Su-Su Zheng; Bo-Heng Zhang; Shuang-Jian Qiu
Journal:  Oncogene       Date:  2021-03-19       Impact factor: 9.867

Review 4.  Up-to-Date Pathologic Classification and Molecular Characteristics of Intrahepatic Cholangiocarcinoma.

Authors:  Taek Chung; Young Nyun Park
Journal:  Front Med (Lausanne)       Date:  2022-03-31

5.  HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1.

Authors:  Chu-Yu Jing; Yi-Peng Fu; Yong Yi; Mei-Xia Zhang; Su-Su Zheng; Jin-Long Huang; Wei Gan; Xin Xu; Jia-Jia Lin; Juan Zhang; Shuang-Jian Qiu; Bo-Heng Zhang
Journal:  J Immunother Cancer       Date:  2019-03-18       Impact factor: 13.751

6.  Integrated tumor stromal features of hepatocellular carcinoma reveals two distinct subtypes with prognostic/predictive significance.

Authors:  Wei Li; Jun Han; Kefei Yuan; Hong Wu
Journal:  Aging (Albany NY)       Date:  2019-07-12       Impact factor: 5.682

7.  A Novel Nomogram Based on Hepatic and Coagulation Function for Evaluating Outcomes of Intrahepatic Cholangiocarcinoma After Curative Hepatectomy: A Multi-Center Study of 653 Patients.

Authors:  Yunshi Cai; Bohan Zhang; Jiaxin Li; Hui Li; Hailing Liu; Kunlin Xie; Chengyou Du; Hong Wu
Journal:  Front Oncol       Date:  2021-07-12       Impact factor: 6.244

Review 8.  Significant Response to Camrelizumab Plus Targeted Drugs in Recurrent Intrahepatic Cholangiocarcinoma: a Case Report and Literature Review.

Authors:  Peixin Huang; Yingting Zhou; Yi Chen
Journal:  J Gastrointest Cancer       Date:  2021-07-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.